OpenAI Launches GPT-Rosalind: An AI to Accelerate Drug Discovery and Genomic Research OpenAI has launched GPT-Rosalind, an AI model designed to accelerate drug discovery and genomic research.
AI acquisition in biotech: a strategic signal for the market An acquisition in AI biotech highlights the race for specialization: data, vertical expertise and workflows become the real competitive advantage.